🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary aims of this study is to determine the efficacy and tolerabilit...
Status
Active Not Recruiting
Location
University of Alabama at Birmingham
Start Date
2015-01
Trial ID
NCT02181257
Treatments Being Tested
The purpose of this study is to examine the effectiveness of the DynaCleft®...
Status
Terminated
Location
The University of Texas Health Science Center at Houston
Start Date
2020-09-21
Trial ID
NCT04455035
Treatments Being Tested
The goal of this clinical trial is to determine if implementing a controlle...
Status
Not Yet Recruiting
Location
Kingston Health Sciences Centre
Start Date
2026-06
Trial ID
NCT07629648
The goal of this observational study is to evaluate the feasibility and acc...
Status
Completed
Location
University of Colorado, Anschutz
Start Date
2025-09-03
Trial ID
NCT07005362
Treatments Being Tested
Diabetic macular edema (DME) is a leading cause of vision loss in patients ...
Status
Completed
Location
Benha University
Start Date
2022-01-01
Trial ID
NCT07663370
Treatments Being Tested
This Phase I/II clinical trial aims to test the effectiveness of a new subl...
Status
Completed
Location
Hospital Descentralizado Dr. Marcial V. Quiroga.
Start Date
2024-12-15
Trial ID
NCT06812221
The purpose of this study is to determine the occurrence of scarring of the...
Status
Completed
Location
Duke University Health System
Start Date
2022-05-09
Trial ID
NCT05328713
Treatments Being Tested
The primary purpose of the study is to compare the occurrence of major cong...
Status
Active Not Recruiting
Location
Eisai Trial Site #1
Start Date
2025-01-03
Trial ID
NCT06744673
Treatments Being Tested
Glioblastoma is a rare, aggressive brain tumor that leads to death within 2...
Status
Active Not Recruiting
Location
BPGbio
Start Date
2021-03-01
Trial ID
NCT07674095